Dr. Mario Sznol graduated from Rice University and Baylor College of Medicine (BCM) in Houston, Texas.
He trained in internal medicine at BCM and completed a medical oncology fellowship in the Department of Neoplastic Diseases, Mount Sinai Hospital, New York. He spent the next twelve years in the Biologics Evaluation Section (BES), Investigational Drug Branch (IDB), Cancer Therapy Evaluation Program of the National Cancer Institute, and was Head of the BES from 1994-1999. He attended on the inpatient units of the Biological Response Modifiers Program, NCI, from 1988-1996 and the Immunotherapy Service of the Surgery Branch, NCI, from 1997-1999. From 1999 to 2004 he was a Vice President and Executive Officer of Vion Pharmaceuticals in New Haven, Connecticut. He is currently Professor of Internal Medicine at Yale University School of Medicine, Deputy Section Chief of Medical Oncology, Leader of the Melanoma Translational Working Group, and Co-Director of Yale SPORE in Skin Cancer.